Literature DB >> 41876

Hepatic enzymes of tyrosine metabolism in tyrosinemia II.

L A Goldsmith, J Thorpe, C R Roe.   

Abstract

A middle-aged adult male with a mild form of tyrosinemia II (Richner-Hanhart syndrome) is described. Treatment with a low-tyrosine diet caused a fall in plasma tyrosine and clearing of the hyperkeratosis of the soles. Liver biopsy of this patient revealed low but measurable levels of cytoplasmic tyrosine aminotransferase and elevated levels of the mitochondrial tyrosine-metabolizing enzyme aspartate aminotransferase. It is hypothesized that these enzymes have been induced in sufficient amounts to account for the mild clinical course.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 41876     DOI: 10.1111/1523-1747.ep12541401

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  3 in total

1.  Hepatic tyrosine aminotransferase in tyrosinaemia type II.

Authors:  K Kida; M Takahashi; Y Fujisawa; H Matsuda; H Machino; Y Miki
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

2.  Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II.

Authors:  L A Goldsmith; J M Thorpe; R F Marsh
Journal:  Biochem Genet       Date:  1981-08       Impact factor: 1.890

3.  The human tyrosine aminotransferase gene: characterization of restriction fragment length polymorphisms and haplotype analysis in a family with tyrosinemia type II.

Authors:  E M Westphal; E Natt; T Grimm; M Odievre; G Scherer
Journal:  Hum Genet       Date:  1988-07       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.